Dark Forest Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Dark Forest Capital Management's RPRX Position: Q2 2026 in Review
Dark Forest Capital Management increased its Royalty Pharma (RPRX) stake by 20% in Q2 2026, buying an estimated $1.19M and bringing the position to 134,982 shares worth $7.57M. The position accounts for 0.49% of the portfolio, ranked #15.
Dark Forest Capital Management first reported a position in RPRX in Q2 2022 and has held it in 12 quarters since. The position peaked at $10.8M in Q4 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Dark Forest Capital Management held 134,982 shares of Royalty Pharma worth $7.57M as of Q2 2026.
- Dark Forest Capital Management bought 22,920 Royalty Pharma shares in Q2 2026, an estimated $1.19M.
- Royalty Pharma made up 0.49% of Dark Forest Capital Management's portfolio in Q2 2026, its #15 holding.
- Dark Forest Capital Management first reported a position in Royalty Pharma in Q2 2022 and has held it in 12 quarters since.
- Dark Forest Capital Management's Royalty Pharma position peaked at $10.8M in Q4 2025.
- 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.